The nano-micellar curcumin improves International Prostate Symptoms Score (IPSS) in patients with benign prostatic hyperplasia: a randomized clinical trial
Author:
Funder
IR.QUMS.REC.
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
https://link.springer.com/content/pdf/10.1007/s00345-023-04512-x.pdf
Reference25 articles.
1. AbdelRazek M, Abolyosr A, Mhammed O, Fathi A, Talaat M, Hassan A (2022) Prospective comparison of tadalafil 5 mg alone, silodosin 8 mg alone, and the combination of both in treatment of lower urinary tract symptoms related to benign prostatic hyperplasia. World J Urol 40:2063–2013. https://doi.org/10.1007/s00345-022-04071-7
2. Guo Z, He J, Huang L, Wang Z, Hu P, Wang S et al (2022) Prevalence and risk factors of incidental prostate cancer in certain surgeries for benign prostatic hyperplasia: a systematic review and meta-analysis. Int Braz J Urol 48:915–944. https://doi.org/10.1590/S1677-5538.IBJU.2021.0653
3. Rastrelli G, Cipriani S, Lotti F, Cellai I, Comeglio P, Filippi S et al (2022) Testosterone does not affect lower urinary tract symptoms while improving markers of prostatitis in men with benign prostatic hyperplasia: a randomized clinical trial. J Endocrinol Invest 45:1413–1438. https://doi.org/10.1007/s40618-022-01776-9
4. Plochocki A, King B (2022) Medical treatment of benign prostatic hyperplasia. Urol Clin North Am 49:231–239. https://doi.org/10.1016/j.ucl.2021.12.003
5. Elterman D, Gao B, Lu S, Bhojani N, Zorn KC, Chughtai B (2022) New technologies for treatment of benign prostatic hyperplasia. Urol clin North Am 49:11–22. https://doi.org/10.1016/j.ucl.2021.07.007
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Curcumin nanopreparations: recent advance in preparation and application;Biomedical Materials;2024-08-27
2. Medical Advancements in Benign Prostatic Hyperplasia Treatments;Current Urology Reports;2024-03-07
3. Nanocarrier-mediated curcumin delivery: An adjuvant strategy for CNS disease treatment;Experimental Biology and Medicine;2023-12-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3